bioRxiv / medRxiv
open access
Biocatalytic Production of Galantamine in Yeast through Cytochrome P450 Optimization
Galantamine is a pharmaceutically relevant Amaryllidaceae alkaloid used for the treatment of Alzheimer's disease. Its structural complexity and low abundance in plants motivate the development of alternative manufacturing routes. Here, we established the first engineered yeast platform for the bioca
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Recent developments and challenges of biocatalytic processes in the pharmaceutical industry#1278839
- Chemical and Biological Reaction Engineering#66811
- Enzyme-Based Electrobiotechnological Synthesis#1278838
- Making technology for production of bioethanol from lignocellulose economically feasible: plant wide simulations#640723
- Making technology for production of bioethanol from lignocellulose economically feasible: plant wide simulations#640722
Record · ID 1278900
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive